These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

626 related articles for article (PubMed ID: 23527737)

  • 1. Liver disease in alpha-1 antitrypsin deficiency: current understanding and future therapy.
    Teckman JH
    COPD; 2013 Mar; 10 Suppl 1():35-43. PubMed ID: 23527737
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Hepatic involvement in hereditary alpha-1-antitrypsin deficiency].
    Lachaux A; Dumortier J
    Rev Mal Respir; 2014 Apr; 31(4):357-64. PubMed ID: 24750955
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Advances in alpha-1-antitrypsin deficiency liver disease.
    Teckman JH; Jain A
    Curr Gastroenterol Rep; 2014 Jan; 16(1):367. PubMed ID: 24338605
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alpha-1-Antitrypsin Deficiency Liver Disease.
    Patel D; Teckman JH
    Clin Liver Dis; 2018 Nov; 22(4):643-655. PubMed ID: 30266154
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alpha-1 antitrypsin and liver disease: mechanisms of injury and novel interventions.
    Teckman JH; Mangalat N
    Expert Rev Gastroenterol Hepatol; 2015 Feb; 9(2):261-8. PubMed ID: 25066184
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical and histologic features of adults with alpha-1 antitrypsin deficiency in a non-cirrhotic cohort.
    Clark VC; Marek G; Liu C; Collinsworth A; Shuster J; Kurtz T; Nolte J; Brantly M
    J Hepatol; 2018 Dec; 69(6):1357-1364. PubMed ID: 30138687
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Indomethacin increases liver damage in a murine model of liver injury from alpha-1-antitrypsin deficiency.
    Rudnick DA; Shikapwashya O; Blomenkamp K; Teckman JH
    Hepatology; 2006 Oct; 44(4):976-82. PubMed ID: 17006946
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pathogenesis of chronic liver injury and hepatocellular carcinoma in alpha-1-antitrypsin deficiency.
    Perlmutter DH
    Pediatr Res; 2006 Aug; 60(2):233-8. PubMed ID: 16864711
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alpha-1-antitrypsin deficiency: Genetic variations, clinical manifestations and therapeutic interventions.
    Hazari YM; Bashir A; Habib M; Bashir S; Habib H; Qasim MA; Shah NN; Haq E; Teckman J; Fazili KM
    Mutat Res Rev Mutat Res; 2017 Jul; 773():14-25. PubMed ID: 28927525
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A polymorphism of the alpha1-antitrypsin gene represents a risk factor for liver disease.
    Chappell S; Hadzic N; Stockley R; Guetta-Baranes T; Morgan K; Kalsheker N
    Hepatology; 2008 Jan; 47(1):127-32. PubMed ID: 17972336
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathophysiology of Alpha-1 Antitrypsin Deficiency Liver Disease.
    Teckman JH; Blomenkamp KS
    Methods Mol Biol; 2017; 1639():1-8. PubMed ID: 28752441
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alpha1-antitrypsin deficiency in childhood.
    Teckman JH
    Semin Liver Dis; 2007 Aug; 27(3):274-81. PubMed ID: 17682974
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analyses of hepatocellular proliferation in a mouse model of alpha-1-antitrypsin deficiency.
    Rudnick DA; Liao Y; An JK; Muglia LJ; Perlmutter DH; Teckman JH
    Hepatology; 2004 Apr; 39(4):1048-55. PubMed ID: 15057909
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Recent progress of pathogenesis and treatment in alpha 1-antitrypsin deficiency].
    Ozaki I; Zern MA
    Nihon Rinsho; 1999 Sep; 57(9):2145-51. PubMed ID: 10497421
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Z and Mmalton-1-antitrypsin deficiency-associated hepatocellular carcinoma: a genetic study.
    Francalanci P; Santorelli FM; Saccani S; Bonetti MF; Medicina D; Coni P; Faa G; Callea F
    Liver Int; 2009 Nov; 29(10):1593-6. PubMed ID: 19744266
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alpha-1-antitrypsin deficiency: a new paradigm for hepatocellular carcinoma in genetic liver disease.
    Rudnick DA; Perlmutter DH
    Hepatology; 2005 Sep; 42(3):514-21. PubMed ID: 16044402
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heteropolymerization of α-1-antitrypsin mutants in cell models mimicking heterozygosity.
    Laffranchi M; Berardelli R; Ronzoni R; Lomas DA; Fra A
    Hum Mol Genet; 2018 May; 27(10):1785-1793. PubMed ID: 29538751
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitative Lipid Profiling Reveals Major Differences between Liver Organoids with Normal Pi*M and Deficient Pi*Z Variants of Alpha-1-antitrypsin.
    Pérez-Luz S; Lalchandani J; Matamala N; Barrero MJ; Gil-Martín S; Saz SR; Varona S; Monzón S; Cuesta I; Justo I; Marcacuzco A; Hierro L; Garfia C; Gomez-Mariano G; Janciauskiene S; Martínez-Delgado B
    Int J Mol Sci; 2023 Aug; 24(15):. PubMed ID: 37569847
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Survival Advantage of Both Human Hepatocyte Xenografts and Genome-Edited Hepatocytes for Treatment of α-1 Antitrypsin Deficiency.
    Borel F; Tang Q; Gernoux G; Greer C; Wang Z; Barzel A; Kay MA; Shultz LD; Greiner DL; Flotte TR; Brehm MA; Mueller C
    Mol Ther; 2017 Nov; 25(11):2477-2489. PubMed ID: 29032169
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alpha-1 Antitrypsin Deficiency Liver Disease.
    Suri A; Patel D; Teckman JH
    Clin Liver Dis; 2022 Aug; 26(3):391-402. PubMed ID: 35868681
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.